Prolonged QRS duration and severity of mitral regurgitation are unfavorable prognostic markers of heart failure in patients with nonischemic dilated cardiomyopathy

Circulation Journal

Volumn 70, Issue 1, 2006, Pages 57-62

  Amiya, Eisuke ^a,b   Tanabe, Kengo ^a   Ikari, Yuji ^a   Nakajima, Yoshihiro ^a   Hara, Kazuhiro ^a  

^a MITSUI MEMORIAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Heart failure; Mitral regurgitation; Nonischemic dilated cardiomyopathy; QRS duration

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CARVEDILOL; CELIPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; TEMOCAPRIL; TRANDOLAPRIL; VALSARTAN;

ADULT; AGED; ARTICLE; BODY MASS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTIVARIATE ANALYSIS; PREDICTION; PROPORTIONAL HAZARDS MODEL; QRS COMPLEX; SURVIVAL;

AGED; ARRHYTHMIA; ATRIAL FIBRILLATION; CARDIOMYOPATHY, DILATED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 29644438452     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.57     Document Type: Article

References (23)

1. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981; 47: 525-531.
2. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831-836.
3. Azuma A, Matsuo A, Nakamura T, Kawasaki T, Yamamoto K, Hyogo M, et al. Improved survival of idiopathic dilated cardiomyopathy in the 1990s. Jpn Circ J 1999; 63: 333-338.
4. Hara Y, Hamada M, Shigematsu Y, Ohtsuka T, Ogimoto A, Suzuki J, et al. Effect of beta-blocker therapy in elderly patients with dilated cardiomyopathy. Circ J 2003; 67: 826-829.
5. Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, et al. Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction: Comparison with nonischemic cardiomyopathy. Circ J 2005; 69: 143-149.
6. Tsutsui H. Novel pathophysiological insight and treatment strategies for heart failure: Lessons from mice and patients. Circ J 2004; 68: 1095-1103.
7. MERIT-HF investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
8. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345: 1667-1675.
9. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1658.
10. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure (SOLVD Investigators). Circulation 1992; 86: 431-438.
11. Gavazzi A, De Maria R, Renosto G, Moro A, Borgia M, Caroli A, et al. The spectrum of left ventricular size in dilated cardiomyopathy: Clinical correlates and prognostic implications: SPIC (Italian Multicenter Cardiomyopathy Study) Group. Am Heart J 1993; 125: 410-422.
12. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. Am Heart J 2002; 143: 1085-1091.
13. Murkofsky RL, Dangas G, Diamond JA, Mehta D, Schaffer A, Ambrose JA. A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction [see Comment]. J Am Coll Cardiol 1998; 32: 476-482.
14. Sandhu R, Bahler RC. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. Am J Cardiol 2004; 93: 244-246.
15. Rouleau F, Merheb M, Geffroy S, Berthelot J, Chaleil D, Dupuis JM, et al. Echocardiographic assessment of the interventricular delay of activation and correlation to the QRS width in dilated cardiomyopathy. Pacing Clin Electrophysiol 2001; 24: 1500-1506.
16. Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: Decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991; 122: 763-771.
17. Bach DS, Bolling SF. Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J 1995; 129: 1165-1170.
18. Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 1995; 109: 676-682; discussion 682-683.
19. Rossi A, Golia G, Gasparini G, Prioli MA, Anselmi M, Zardini P. Left atrial filling volume can be used to reliably estimate the regurgitant volume in mitral regurgitation. J Am Coll Cardiol 1999; 33: 212-217.
20. Rossi A, Cicoira M, Zanolla L, Sandrini R, Golia G, Zardini P, et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 1425.
21. Matsumori A, Furukawa Y, Hasegawa K, Sato Y, Nakagawa H, Morikawa Y, et al. Epidemiologic and clinical characteristics of cardiomyopathies in Japan: Results from nationwide surveys. Circ J 2002; 66: 323-336.
22. Alonso C, Leclercq C, Victor F, Mansour H, de Place C, Pavin D, et al. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am J Cardiol 1999; 84: 1417-1421.
23. Etienne Y, Mansourati J, Touiza A, Gilard M, Bertault-Valls V, Guillo P, et al. Evaluation of left ventricular function and mitral regurgitation during left ventricular-based pacing in patients with heart failure. Eur J Heart Fail 2001; 3: 441-417.